- Library Top Page
- New Books List
- New Journals List
- Books Ranking
- My Library Login
- Electronic Journals (Search / Notes)
- Floor Map
- Help
Induced Pluripotent Stem Cells. 1st ed. 2012
- Format:
- eBook
- Responsibility:
- by Sibel Yildirim
- Published:
- New York, NY : Springer New York : Imprint: Springer, 2012
- Authors:
- Series:
- SpringerBriefs in Stem Cells ;
- ISBN:
- 9781461422068 [146142206X]
- Notes:
- Induced Pluripotent Stem (iPS) cells are mature cells that have been genetically reprogrammed so that they return to their embryonic state. It is not yet known if iPS stem cells and embryonic stem cells differ significantly. Today many fundamental belief systems in biology are shifting towards accepting that mature body cells can be reverted to an embryonic state without the help of eggs or embryos. With their changed identities, iPS cells are then ready to serve as new tools for research in the fields of disease pathogenesis, drug discovery, oncology, and cell transplantation. One example of this would be using iPS from a patient’s mature cells to repair damaged tissue; it is thought that there would be very low incidence of rejection of the ‘new’ tissue in these cases. For the last four years, this therapeutic promise has been studied by hundreds of researchers worldwide in an effort to understand the ability of these cells to reverse their biological clocks. Table of contents: Introduction -- Pluripotent C
Induced Pluripotent Stem (iPS) cells are mature cells that have been genetically reprogrammed so that they return to their embryonic state. It is not yet known if iPS stem cells and embryonic stem cells differ significantly. Today many fundamental belief systems in biology are shifting towards accepting that mature body cells can be reverted to an embryonic state without the help of eggs or embryos. With their changed identities, iPS cells are then ready to serve as new tools for research in the fields of disease pathogenesis, drug discovery, oncology, and cell transplantation. One example of this would be using iPS from a patient’s mature cells to repair damaged tissue; it is thought that there would be very low incidence of rejection of the ‘new’ tissue in these cases. For the last four years, this therapeutic promise has been studied by hundreds of researchers worldwide in an effort to understand the ability of these cells to reverse their biological clocks. - Local Notes:
- 岐阜大学構成員専用E-BOOKS (Gifu University members only)
Similar Items:
Humana Press : Imprint: Humana |
Springer Netherlands : Imprint: Springer |
Humana Press : Imprint: Humana |
Humana Press : Imprint: Humana |
Humana Press : Imprint: Humana |
Humana Press, a part of Springer Science+Business Media, LLC |
Humana Press : Imprint: Humana |
Springer Science+Business Media, LLC |
Springer New York : Imprint: Springer |
Springer Science+Business Media, LLC |
Springer Berlin Heidelberg : Imprint: Springer |
Springer Science+Business Media, LLC |